<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/AECAEAE2-CDC1-4435-8666-CDBD4230E298"><gtr:id>AECAEAE2-CDC1-4435-8666-CDBD4230E298</gtr:id><gtr:name>The Electrospinning Company Limited</gtr:name><gtr:address><gtr:line1>R27 Rutherford Appleton Laboratory
Harwell Oxford</gtr:line1><gtr:city>Didcot</gtr:city><gtr:postCode>OX11 0QX</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>P</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/AECAEAE2-CDC1-4435-8666-CDBD4230E298" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="gtr:organisationParticipantRole"><gtr:id>AECAEAE2-CDC1-4435-8666-CDBD4230E298</gtr:id><gtr:name>The Electrospinning Company Limited</gtr:name><gtr:address><gtr:line1>R27 Rutherford Appleton Laboratory
Harwell Oxford</gtr:line1><gtr:city>Didcot</gtr:city><gtr:postCode>OX11 0QX</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PARTICIPANT</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_PARTICIPANT</gtr:name></gtr:role></gtr:roles><gtr:offerGrant>15350.0</gtr:offerGrant><gtr:projectCost>21879.0</gtr:projectCost></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/CAF8A2BC-4465-47EF-BB37-92B15D2878CB" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="gtr:organisationParticipantRole"><gtr:id>CAF8A2BC-4465-47EF-BB37-92B15D2878CB</gtr:id><gtr:name>Collagen Solutions (UK) LImited</gtr:name><gtr:address><gtr:line1>c/o Shepherd and Wedderburn LLP
Condor House
10 St Paul's Churchyard</gtr:line1><gtr:city>London</gtr:city><gtr:postCode>EC4M 8AL</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>PARTICIPANT</gtr:name></gtr:role></gtr:roles><gtr:offerGrant>7585.0</gtr:offerGrant><gtr:projectCost>10837.0</gtr:projectCost></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/12A6D0FB-6BC3-43CD-A97A-12010F475533"><gtr:id>12A6D0FB-6BC3-43CD-A97A-12010F475533</gtr:id><gtr:firstName>Robert</gtr:firstName><gtr:surname>McKean</gtr:surname><gtr:roles><gtr:role><gtr:name>PROJECT_MANAGER</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=131928"><gtr:id>D2402B71-78A3-410F-938B-DB99616E82D3</gtr:id><gtr:title>Bio-synthetic hybrid material for use in internal wounding healing</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Feasibility Studies</gtr:grantCategory><gtr:grantReference>131928</gtr:grantReference><gtr:abstractText>The global market for surgical meshes is over $1 billion and increasing due to increasing obesity and aging populations. Despite being a well-established market there remain unmet needs and attractive opportunities for advanced mesh materials which promote rapid endogenous healing and reduce risk of rejection and infection. In this proposal two SMEs, The Electrospinning Company Ltd. and Collagen Solutions plc., will combine their expertise in synthetic and biological materials to develop a ?bio-synthetic? hybrid material that combines the advantages of synthetic polymers, such as flexibility, strength and consistency, with the bio-performance advantages of collagen, such as providing cell recognition sites for cell adhesion, proliferation and ultimately improved tissue regeneration at wound sites. Electrospinning technology will be used to create a non-woven mesh with dual properties.</gtr:abstractText><gtr:fund><gtr:end>2015-09-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/E18E2F0F-AC7D-4E02-9559-669F7C8FEC74"><gtr:id>E18E2F0F-AC7D-4E02-9559-669F7C8FEC74</gtr:id><gtr:name>Innovate UK</gtr:name></gtr:funder><gtr:start>2015-06-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>22935</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications/><gtr:identifiers><gtr:identifier type="RCUK">131928</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>